Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans.

Zeiss CJ, Gatti DM, Toro-Salazar O, Davis C, Lutz CM, Spinale F, Stearns T, Furtado MB, Churchill GA.

G3 (Bethesda). 2019 Aug 8;9(8):2637-2646. doi: 10.1534/g3.119.400232.

2.

Robust mouse tracking in complex environments using neural networks.

Geuther BQ, Deats SP, Fox KJ, Murray SA, Braun RE, White JK, Chesler EJ, Lutz CM, Kumar V.

Commun Biol. 2019 Mar 29;2:124. doi: 10.1038/s42003-019-0362-1. eCollection 2019.

3.

Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Zhou Y, Carmona S, Muhammad AKMG, Bell S, Landeros J, Vazquez M, Ho R, Franco A, Lu B, Dorn GW 2nd, Wang S, Lutz CM, Baloh RH.

J Clin Invest. 2019 Mar 18;130:1756-1771. doi: 10.1172/JCI124194. eCollection 2019 Mar 18.

4.

Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes.

Møller DS, Alber M, Nordsmark M, Nyeng TB, Lutz CM, Hoffmann L.

Radiother Oncol. 2019 Feb;131:174-178. doi: 10.1016/j.radonc.2018.09.018. Epub 2018 Oct 16.

PMID:
30340776
5.

Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development.

Racine JJ, Stewart I, Ratiu J, Christianson G, Lowell E, Helm K, Allocco J, Maser RS, Chen YG, Lutz CM, Roopenian D, Schloss J, DiLorenzo TP, Serreze DV.

Diabetes. 2018 May;67(5):923-935. doi: 10.2337/db17-1467. Epub 2018 Feb 22.

6.

The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.

Berg M, Lorenzen EL, Jensen I, Thomsen MS, Lutz CM, Refsgaard L, Nissen HD, Offersen BV.

Acta Oncol. 2018 Jan;57(1):113-119. doi: 10.1080/0284186X.2017.1406139. Epub 2017 Dec 5.

PMID:
29205080
7.

The NARLAL2 dose escalation trial: dosimetric implications of inter-fractional changes in organs at risk.

Hoffmann L, Knap MM, Khalil AA, Lutz CM, Sloth Møller D.

Acta Oncol. 2018 Apr;57(4):473-479. doi: 10.1080/0284186X.2017.1366049. Epub 2017 Aug 23.

PMID:
28830293
8.

Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.

Møller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Drøgemüller Lund M, Hansen O, Schytte T, Khalil AA, Knap MM, Nyhus CH, Ottosson W, Sibolt P, Borissova S, Josipovic M, Persson G, Appelt AL.

Radiother Oncol. 2017 Aug;124(2):311-317. doi: 10.1016/j.radonc.2017.06.022. Epub 2017 Jul 5.

9.

Reliability of dose volume constraint inference from clinical data.

Lutz CM, Møller DS, Hoffmann L, Knap MM, Alber M.

Phys Med Biol. 2017 Apr 21;62(8):3250-3262. doi: 10.1088/1361-6560/aa63d4.

PMID:
28350545
10.

C9orf72 is required for proper macrophage and microglial function in mice.

O'Rourke JG, Bogdanik L, Yáñez A, Lall D, Wolf AJ, Muhammad AK, Ho R, Carmona S, Vit JP, Zarrow J, Kim KJ, Bell S, Harms MB, Miller TM, Dangler CA, Underhill DM, Goodridge HS, Lutz CM, Baloh RH.

Science. 2016 Mar 18;351(6279):1324-9. doi: 10.1126/science.aaf1064.

11.

C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.

O'Rourke JG, Bogdanik L, Muhammad AKMG, Gendron TF, Kim KJ, Austin A, Cady J, Liu EY, Zarrow J, Grant S, Ho R, Bell S, Carmona S, Simpkinson M, Lall D, Wu K, Daughrity L, Dickson DW, Harms MB, Petrucelli L, Lee EB, Lutz CM, Baloh RH.

Neuron. 2015 Dec 2;88(5):892-901. doi: 10.1016/j.neuron.2015.10.027.

12.

Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy.

Bogdanik LP, Osborne MA, Davis C, Martin WP, Austin A, Rigo F, Bennett CF, Lutz CM.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):E5863-72. doi: 10.1073/pnas.1509758112. Epub 2015 Oct 12.

13.

Setup error and motion during deep inspiration breath-hold breast radiotherapy measured with continuous portal imaging.

Lutz CM, Poulsen PR, Fledelius W, Offersen BV, Thomsen MS.

Acta Oncol. 2016;55(2):193-200. doi: 10.3109/0284186X.2015.1045625. Epub 2015 May 18.

PMID:
25984928
14.

Optimizing mouse models of neurodegenerative disorders: are therapeutics in sight?

Lutz CM, Osborne MA.

Future Neurol. 2013;9(1):67-75. doi: 10.2217/fnl.13.66. Epub 2013 Dec 16.

15.

Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, Xu X, Davis C, Wooley J, Goldhamer DJ, Lutz CM, Rich MM, Sumner CJ.

J Neurosci. 2012 Jun 20;32(25):8703-15. doi: 10.1523/JNEUROSCI.0204-12.2012.

16.

Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy.

Lutz CM, Kariya S, Patruni S, Osborne MA, Liu D, Henderson CE, Li DK, Pellizzoni L, Rojas J, Valenzuela DM, Murphy AJ, Winberg ML, Monani UR.

J Clin Invest. 2011 Aug;121(8):3029-41. doi: 10.1172/JCI57291. Epub 2011 Jul 25.

17.

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies.

Miki T, Zwingman TA, Wakamori M, Lutz CM, Cook SA, Hosford DA, Herrup K, Fletcher CF, Mori Y, Frankel WN, Letts VA.

Neuroscience. 2008 Jul 31;155(1):31-44. doi: 10.1016/j.neuroscience.2008.05.028. Epub 2008 Jul 1.

18.

The Mouse Genome Database (MGD): integrating biology with the genome.

Bult CJ, Blake JA, Richardson JE, Kadin JA, Eppig JT, Baldarelli RM, Barsanti K, Baya M, Beal JS, Boddy WJ, Bradt DW, Burkart DL, Butler NE, Campbell J, Corey R, Corbani LE, Cousins S, Dene H, Drabkin HJ, Frazer K, Garippa DM, Glass LH, Goldsmith CW, Grant PL, King BL, Lennon-Pierce M, Lewis J, Lu I, Lutz CM, Maltais LJ, McKenzie LM, Miers D, Modrusan D, Ni L, Ormsby JE, Qi D, Ramachandran S, Reddy TB, Reed DJ, Sinclair R, Shaw DR, Smith CL, Szauter P, Taylor B, Vanden Borre P, Walker M, Washburn L, Witham I, Winslow J, Zhu Y; Mouse Genome Database Group.

Nucleic Acids Res. 2004 Jan 1;32(Database issue):D476-81.

19.

Rules and guidelines for mouse gene, allele, and mutation nomenclature: a condensed version.

Maltais LJ, Blake JA, Chu T, Lutz CM, Eppig JT, Jackson I.

Genomics. 2002 Apr;79(4):471-4. No abstract available.

PMID:
11944975
20.

Corralling conditional mutations: a unified resource for mouse phenotypes.

Eppig JT, Blake JA, Burkart DL, Goldsmith CW, Lutz CM, Smith CL.

Genesis. 2002 Feb;32(2):63-5. No abstract available.

PMID:
11857778
22.

Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner.

Lorenzon NM, Lutz CM, Frankel WN, Beam KG.

J Neurosci. 1998 Jun 15;18(12):4482-9.

23.
24.

Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice.

Cox GA, Lutz CM, Yang CL, Biemesderfer D, Bronson RT, Fu A, Aronson PS, Noebels JL, Frankel WN.

Cell. 1997 Oct 3;91(1):139-48. Erratum in: Cell 1997 Dec 12;91(6):861.

25.

Neuropeptide Y receptor genes on human chromosome 4q31-q32 map to conserved linkage groups on mouse chromosomes 3 and 8.

Lutz CM, Frankel WN, Richards JE, Thompson DA.

Genomics. 1997 May 1;41(3):498-500. Erratum in: Genomics 1997 Sep 1;44(2):251-2.

PMID:
9169155
26.

Absence epilepsy in tottering mutant mice is associated with calcium channel defects.

Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, Copeland NG, Jenkins NA.

Cell. 1996 Nov 15;87(4):607-17.

27.

Congenic strains reveal effects of the epilepsy quantitative trait locus, El2, separate from other El loci.

Frankel WN, Johnson EW, Lutz CM.

Mamm Genome. 1995 Dec;6(12):839-43.

PMID:
8747921
28.

New seizure frequency QTL and the complex genetics of epilepsy in EL mice.

Frankel WN, Valenzuela A, Lutz CM, Johnson EW, Dietrich WF, Coffin JM.

Mamm Genome. 1995 Dec;6(12):830-8.

PMID:
8747920
29.

Genetic epilepsy model derived from common inbred mouse strains.

Frankel WN, Taylor BA, Noebels JL, Lutz CM.

Genetics. 1994 Oct;138(2):481-9.

30.

Transcription vectors that facilitate the identification and mapping of RNA splice sites in genomic DNA.

Reilly JD, Melhem RF, Lutz CM, Edmonds M.

DNA Cell Biol. 1990 Sep;9(7):535-42.

PMID:
2222814
31.

Nitrones. 6. -(5-Nitroimidazol-2-yl)-N-substituted nitrones.

Bambury RE, Lutz CM, Miller LF, Kim HK, Ritter HW.

J Med Chem. 1973 May;16(5):566-8. No abstract available.

PMID:
4198029

Supplemental Content

Support Center